VALN Valneva SE
Healthcare$5.93+1.02%ClosedMarket Cap: $528.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
5.85
P/S
3.17
EV/EBITDA
-6.92
DCF Value
$-4.18
FCF Yield
-14.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.5%
Operating Margin
-68.8%
Net Margin
-88.3%
ROE
-106.2%
ROA
-37.1%
ROIC
-36.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $30.9M | 15.3% | $-23.7M | $-32.1M | $— | — |
| Q4 null | $47.7M | 24.4% | $-27.7M | $-50.0M | $— | — |
| FY null | $174.7M | 38.7% | $-81.6M | $-115.2M | $— | — |
| Q3 null | $29.4M | 18.7% | $-37.1M | $-44.4M | $— | — |
| Q2 null | $48.3M | 50.1% | $-10.9M | $-11.6M | $— | — |
| Q1 null | $49.2M | 53.2% | $-6.0M | $-9.2M | $— | — |
| Q4 null | $52.9M | 48.6% | $-20.9M | $-37.0M | $— | — |
| FY null | $169.6M | 41.9% | $13.3M | $-12.2M | $— | — |
| Q3 null | $45.8M | 44.0% | $-12.4M | $-9.2M | $— | — |
| Q2 null | $38.1M | 38.3% | $-21.5M | $-24.9M | $— | — |
| Q1 null | $32.8M | 32.3% | $68.2M | $58.9M | $— | — |
| Q4 2023 | $41.9M | 37.8% | $-24.9M | $-32.2M | $-0.46 | — |